MONDAY, April 3, 2023 (HealthDay News) — An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says. Ficlatuzumab used in combination with the already approved targeted drug cetuximab (Erbitux) significantly improvedContinue Reading

THURSDAY, March 30, 2023 (HealthDay News) — Assessing heart roundness may be a new way to diagnose cardiovascular conditions, new research suggests. While doctors now use measures like heart chamber size and systolic function to diagnose and monitor cardiomyopathy and other related heart issues, cardiac sphericity (how round the heartContinue Reading

FRIDAY, March 24, 2023 (HealthDay News) — A medical device used to diagnose and treat pancreatic and bile duct disease is getting attention from the U.S. Food and Drug Administration after pieces have fallen off and remained in patients’ bodies. Previously, the FDA had expressed concern about duodenoscopes because theyContinue Reading